Purchases and Sales Made in Q1 2024 in West Pharmaceutical Services Inc (WST)
This table provides information about the institutional ownership of West Pharmaceutical Services Inc (WST) during Q1 2024. The information is specifically focused on institutions that hold shares of WEST PHARMACEUTICAL SERVICES INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2024
Q1 2024
|
Champlain Investment Partners, LLC
Burlington, VT |
SELL
|
- |
-91.6K- 34.48% |
$31M - $37.8M
|
174K
$36.7M
|
|
|
May 15, 2024
Q1 2024
|
Bamco Inc
New York, NY |
SELL
|
- |
-106K- 10.61% |
$35.8M - $43.7M
|
892K
$188M
|
|
|
May 15, 2024
Q1 2024
|
Durable Capital Partners LP
Bethesda, MD |
SELL
|
- |
-108K- 9.46% |
$36.4M - $44.5M
|
1.03M
$217M
|
|
|
May 15, 2024
Q1 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-124K- 82.74% |
$41.9M - $51.1M
|
25.8K
$5.45M
|
|
|
May 15, 2024
Q1 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-159K- 12.76% |
$53.7M - $65.6M
|
1.09M
$229M
|
|
|
May 15, 2024
Q1 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-159K- 39.66% |
$53.8M - $65.7M
|
242K
$51M
|
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-178K- 18.88% |
$60.2M - $73.5M
|
765K
$161M
|
|
|
May 14, 2024
Q1 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-180K- 31.34% |
$60.7M - $74.1M
|
393K
$82.9M
|
|
|
May 13, 2024
Q1 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-206K- 96.64% |
$69.8M - $85.2M
|
7.18K
$1.51M
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-215K- 2.77% |
$72.9M - $89M
|
7.56M
$1.59B
|
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-275K- 92.38% |
$93.2M - $114M
|
22.7K
$4.79M
|
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-295K- 12.65% |
$99.6M - $122M
|
2.03M
$429M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-357K- 34.87% |
$121M - $147M
|
667K
$141M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-357K- 34.87% |
$121M - $147M
|
667K
$141M
|